# Patient Care Plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Clara Barton (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI024-SYN
- Date: 2026-01-20
- Fictional facility: St. Posthumous Health Center
- Fictional author: Eleanor Whitcombe, MD
- Calendar frame: modern shifted

## What we are working on

- Exhausted, low, and sleeping three or four hours a night since coming home; feels she is no use to anyone **S**
- Worried that stopping work would let down the families and staff who rely on her, and wonders whether she simply needs a long rest **S**

## Your goals

- Response (PHQ-9 down by at least 50 percent) by twelve weeks. Target: 2026-04-14. Recorded outcome: PHQ-9 7 at twelve weeks, down 61 percent from 18. **S**
- Remission (PHQ-9 below 5) and continuation treatment for at least twelve months after remission. Target: 2026-06-16. Recorded outcome: Remission reached at five months (PHQ-9 4); continuation treatment under way. **S**
- Sleep at least six hours most nights. Target: 2026-04-14. Recorded outcome: About six and a half hours most nights by twelve weeks. **S**
- Phased return to work at no more than 45 hours a week, with no field deployment for at least six months. Target: 2026-06-16. Recorded outcome: Full duties at 45 hours a week from April; no deployment. **S**
- Time with friends or her faith community at least twice a week. Target: 2026-06-16. Recorded outcome: Weekly dinner with friends and weekly services. **S**

## What we agreed to do

- Shared decision-making: combined psychotherapy and an antidepressant for a recurrent, moderately severe episode; she chose cognitive behavioral therapy and sertraline. Guideline: VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**
- Start sertraline 50 mg each morning; check tolerability and safety at two weeks; increase to 100 mg if the PHQ-9 has fallen by less than 50 percent after four to six weeks. Guideline: VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**
- Weekly cognitive behavioral therapy with the clinic psychologist, by video or in person, for about 16 sessions, including behavioral activation and insomnia components. Guideline: VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**
- Collaborative safety plan with warning signs, coping steps, people to contact, the clinic number, and the 988 Suicide & Crisis Lifeline; medicines stored safely and dispensed in 30-day supplies. Guideline: VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024) **S**
- Psychiatry consultation to confirm the diagnosis, exclude bipolar disorder and PTSD, and advise on treatment of a recurrent episode. Guideline: VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**
- PHQ-9 at every visit and at least monthly until remission; suicide-risk review at every visit; continue sertraline for at least twelve months after remission because the episode is recurrent. Guideline: VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**
- Burnout and work: two weeks of medical leave, then a phased return with a 45-hour cap, no field deployment for at least six months, delegation of the families' correspondence, and a peer support group for relief workers. Guideline: VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**
- Sleep and activity: fixed wake time, no work after 8 pm, a daily 30-minute walk, regular meals, and limited alcohol; prolonged bed rest or withdrawal from activity is explained as unhelpful for depression. Guideline: VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**
- Screen for bipolar disorder, PTSD, anxiety, and unhealthy alcohol use, and check thyroid, blood count, vitamin B12, and a metabolic panel for medical contributors to fatigue. Guideline: VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); Depression and Suicide Risk in Adults: Screening (2023) **S**

## Follow-up

- 2026-01-20: Primary care visit for low mood, exhaustion, and poor sleep after returning from a long humanitarian deployment **S**
- 2026-02-03: Two-week sertraline tolerability and safety check, with psychiatry consultation **S**
- 2026-03-03: Six-week depression treatment review **S**
- 2026-04-14: Twelve-week depression treatment review **S**
- 2026-06-16: Five-month depression review in continuation treatment **S**
- 2026-10-13: Periodic adult preventive visit **S**

This teaching document does not replace care from a qualified clinician.
